Andere Sprachen Annexon, Inc.

Aktien

A2P859

US03589W1027

ANNX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 02.05.2024			% 5 Tage	% 1. Jan.
4,66 ^USD	-1,89 %		+1,53 %	+2,64 %

01.04.	ANNEXON, INC. : JPMorgan Chase bekräftigt seine Kaufempfehlung	ZM
27.03.	ANNEXON, INC. : Wells Fargo Securities behält seine Kaufempfehlung bei	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting	01.05.
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting	01.05.
ANNEXON REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(4)	17.04.
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)	16.04.
Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference	03.04.
Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference	03.04.
Annexon Q4 Loss Narrows	26.03.
Annexon, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26.03.
Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones	26.03.
Annexon, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	26.03.
North American Morning Briefing : Stocks Struggle After New Records	22.03.
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)	18.03.
North American Morning Briefing : Inflation Worries Continue to Weigh on Mood	15.03.
North American Morning Briefing : Stock Futures -2-	04.03.
Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference	27.02.
Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference	27.02.
ANNEXON REPORTS INDUCEMENT GRANT TO NEW EMPLOYEE UNDER NASDAQ LISTING RULE 5635(4)	21.02.
Annexon to Host Virtual R&D Day on Guillain-Barré Syndrome, Focusing on its Serious Unmet Need and Annexon’s Novel Therapeutic Approach	21.02.
Annexon to Host Virtual R&D Day on Guillain-Barré Syndrome, Focusing on its Serious Unmet Need and Annexon’s Novel Therapeutic Approach	21.02.
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)	20.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Annexon, Inc.

Aktien

A2P859

US03589W1027

ANNX

Andere Sprachen

Filter